To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.
Clinical trial NCT04955626 · COMPLETED
Trial details
- NCT number
- NCT04955626
- Sponsor
- BioNTech SE
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2023-05-25
- Enrollment
- 16372
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.